Shuttle

安进赌输了。
2021年6月，安进以4亿美元首付款、高至8.5亿美元的潜在里程碑付款以及未来销售分成，从日本制药企业协和麒麟获得OX40单抗rocatinlimab在日本外的全球权益。
引进之后，安进火力全开，推进一系列临床试验。遗憾的是，虽然rocatinlimab在AD领域取得了2项三期临床的成功，却没能...

回复@敦厚的理财小诚实: 看好 Kardia Shuttle，如果成功，就是颠覆性的//@敦厚的理财小诚实:[该内容现已无法查看]

$Shuttle(SHPH)$ 8-K Current report, items 1.01, 1.02, 2.05, and 9.01 Accession Number: 0001493152-25-024618  Act: 34  Size: 258 KB 网页链接

$Shuttle(SHPH)$ 8-K Current report, item 3.01 Accession Number: 0001493152-25-023845  Act: 34  Size: 207 KB 网页链接

$Shuttle(SHPH)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-26-001859  Size: 3 KB 网页链接

$Shuttle(SHPH)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001493152-25-029361  Act: 34  Size: 249 KB 网页链接

$Shuttle(SHPH)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-25-025430  Act: 34  Size: 320 KB 网页链接

$Shuttle(SHPH)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-26-001861  Act: 34  Size: 249 KB 网页链接

$Shuttle(SHPH)$ 8-K Current report, items 1.01, 2.01, 3.02, and 9.01 Accession Number: 0001493152-25-025082  Act: 34  Size: 821 KB 网页链接

$Shuttle(SHPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-022162  Act: 34  Size: 6 MB 网页链接

$Shuttle(SHPH)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-26-004647  Act: 33  Size: 98 KB 网页链接

$Shuttle(SHPH)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-26-000384  Act: 33  Size: 1 KB 网页链接

$Shuttle(SHPH)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-027310  Act: 33  Size: 234 KB 网页链接

$Shuttle(SHPH)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-024089  Act: 33  Size: 416 KB 网页链接

$Shuttle(SHPH)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-26-004782  Act: 34  Size: 228 KB 网页链接